Ultrasound plus proteomic analysis of blood samples may help physicians identify early-stage ovarian cancer and save the lives of many women, according to researchers from the Mount Sinai School of Medicine and Vanderbilt University.
Ultrasound plus proteomic analysis of blood samples may help physicians identify early-stage ovarian cancer and save the lives of many women, according to researchers from the Mount Sinai School of Medicine and Vanderbilt University.
More than 21,500 women annually are diagnosed with the disease, 67% of them at an advanced stage. If ovarian cancer is detected at an early stage, survival is greater than 90%.
Contrast ultrasound may help confirm or eliminate the possibility that biomarkers can accurately detect early-stage ovarian cancer. Contrast agents may significantly improve the diagnostic ability of ultrasound to identify early microvascular changes known to be associated with earlystage ovarian cancer, said Dr. Arthur C. Fleischer, a coauthor of the study and a professor of radiology at Vanderbilt.
“Separately, proteomics and ultrasound are of limited value as early detection tools,” he said. “However, in combination, we will likely be able to shift from an era of diagnosing advanced stage ovarian cancer to that of early-stage disease, and save the lives of many women.”
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.